CircRNA_100782 promotes roliferation and metastasis of gastric most cancers by downregulating tumor suppressor gene Rb by adsorbing miR-574-3p in a sponge kind
Objective: The purpose of this analysis is to research the expression ranges of circRNA_100782 in gastric most cancers tissues, and its carry out of regulating tumor suppressor gene Rb by absorbing miR-574-3p in a sponge kind.
Victims and techniques: qRT-PCR was carried out to detect the expressions of circRNA_100782 at completely completely different phases all through gastric most cancers tissues. CCK-Eight assay was carried out to guage the osteoclast proliferation and differentiation. The correlation between miR-574-3p and circRNA_100782 was detected by statistical analysis. Bioinformatics and Luciferase assay have been carried out to find the interaction and binding web site of circRNA_100782 and miR-574-3p. The mice Rb 3′-UTR have been cloned into the Luciferase reporter vector and miR-574-3p binding mutants have been constructed to validate the inhibited regulation of miR-574-3p to the expression of Rb.
Outcomes: Throughout the current analysis, in distinction with adjoining non-cancerous common tissues, the expressions of circRNA_100782 and Rb have been every downregulated in human gastric most cancers cells. By the use of qRT-PCR and CCK-Eight assay, we found that the expression of circRNA_100782 is expounded to the proliferation of gastric most cancers cells. Along with, we moreover found that circRNA_100782 regulated the migration functionality of gastric most cancers cells by transwell assay.
The bioinformatics prediction and luciferase assay demonstrated that circRNA_100782 can operate a molecular sponge to further regulate the expression of Rb by sponging with miR-574-3p; moreover, circRNA_100782 can operate a ceRNA for miR-574-3p to further regulate the expression of Rb.
Conclusions: On this evaluation, we discovered that circRNA_100782 was downregulated in gastric most cancers cells and is expounded to cell proliferation and invasion by inhibiting tumor suppressor gene Rb by interacting with miR-574-3p.
Olaparib |
|||
GP0126-100 | Glentham Life Sciences | 100 | EUR 83.1 |
Olaparib |
|||
GP0126-100MG | Glentham Life Sciences | 100 mg | EUR 136.8 |
Olaparib |
|||
GP0126-1G | Glentham Life Sciences | 1 g | EUR 514.8 |
Olaparib |
|||
GP0126-250 | Glentham Life Sciences | 250 | EUR 150.4 |
Olaparib |
|||
GP0126-250MG | Glentham Life Sciences | 250 mg | EUR 217.2 |
Olaparib |
|||
T3015-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Olaparib |
Olaparib |
|||
T3015-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Olaparib |
Olaparib |
|||
T3015-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Olaparib |
Olaparib |
|||
T3015-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Olaparib |
Olaparib |
|||
T3015-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Olaparib |
Olaparib |
|||
abx282544-100g | Abbexa | 100 µg | Ask for price |
Olaparib |
|||
abx282544-20g | Abbexa | 20 µg | EUR 106.25 |
Olaparib |
|||
abx282544-50g | Abbexa | 50 µg | EUR 212.5 |
Olaparib-d5 |
|||
T12292-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Olaparib-d5 |
Olaparib-d5 |
|||
T12292-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Olaparib-d5 |
Olaparib-d5 |
|||
T12292-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Olaparib-d5 |
Olaparib-d5 |
|||
T12292-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Olaparib-d5 |
Olaparib-d5 |
|||
T12292-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Olaparib-d5 |
AZD2281 (Olaparib) |
|||
27003 | BPS Bioscience | 250 mg | EUR 200 |
Description: AZD2281, also known as Olaparib, is a poly(ADP-ribose) polymerase 1 (PARP1) inhibitor and an anti-cancer drug being tested in patients with mutations in the genes BRCA1 or BRCA2. |
Olaparib (AZD2281) |
|||
E1KS1060 | EnoGene | 10mg | EUR 303 |
Olaparib (AZD-2281) |
|||
200422 | MedKoo Biosciences | 200.0mg | EUR 90 |
Olaparib [CAS# 763113-22-0] |
|||
O-9201 | LC LABORATORIES | 250 mg | EUR 75 |
Olaparib (AZD2281, Ku-0059436) |
|||
A4154-10 | ApexBio | 10 mg | EUR 40 |
Description: Potent PARP1/PARP2 inhibitor |
Olaparib (AZD2281, Ku-0059436) |
|||
A4154-100 | ApexBio | 100 mg | EUR 128 |
Description: Potent PARP1/PARP2 inhibitor |
Olaparib (AZD2281, Ku-0059436) |
|||
A4154-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
Description: Potent PARP1/PARP2 inhibitor |
Olaparib (AZD2281, Ku-0059436) |
|||
A4154-500 | ApexBio | 500 mg | EUR 384 |
Description: Potent PARP1/PARP2 inhibitor |
Olaparib (AZD2281, Ku-0059436) |
|||
A4154-S | ApexBio | Evaluation Sample | EUR 22 |
Description: Potent PARP1/PARP2 inhibitor |
N-Descyclopropanecarbaldehyde Olaparib |
|||
T36571-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: N-Descyclopropanecarbaldehyde Olaparib |
N-Descyclopropanecarbaldehyde Olaparib |
|||
T36571-1g | TargetMol Chemicals | 1g | Ask for price |
Description: N-Descyclopropanecarbaldehyde Olaparib |
N-Descyclopropanecarbaldehyde Olaparib |
|||
T36571-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: N-Descyclopropanecarbaldehyde Olaparib |
N-Descyclopropanecarbaldehyde Olaparib |
|||
T36571-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: N-Descyclopropanecarbaldehyde Olaparib |
N-Descyclopropanecarbaldehyde Olaparib |
|||
T36571-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: N-Descyclopropanecarbaldehyde Olaparib |
Ola1/ Rat Ola1 ELISA Kit |
|||
ELI-44591r | Lifescience Market | 96 Tests | EUR 1063.2 |
Ola1 (untagged ORF) - Rat Obg-like ATPase 1 (Ola1), (10 ug) |
|||
RN212538 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Ola1 (GFP-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), 200ul, >10^7 TU/mL |
|||
RR212538L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Ola1 (Myc-DDK-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), (10 ug) |
|||
RR212538 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Ola1 (Myc-DDK-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), 200ul, >10^7 TU/mL |
|||
RR212538L3V | Origene Technologies GmbH | 200 µl | Ask for price |
OLA1 |
|||
CSB-CL016318HU1 | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
OLA1 |
|||
CSB-CL016318HU2 | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
OLA1 |
|||
enz-637 | ProSpec Tany | 5µg | EUR 60 |
Description: Recombinant Human Obg-Like ATPase 1 |
Lenti ORF clone of Ola1 (mGFP-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), (10 ug) |
|||
RR212538L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Ola1 (Myc-DDK-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), (10 ug) |
|||
RR212538L3 | Origene Technologies GmbH | 10 µg | Ask for price |
OLA1 siRNA |
|||
20-abx926820 | Abbexa |
|
|
OLA1 siRNA |
|||
20-abx926821 | Abbexa |
|
|
OLA1 siRNA |
|||
20-abx903741 | Abbexa |
|
|
OLA1 (untagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 1 |
|||
SC115293 | Origene Technologies GmbH | 10 µg | Ask for price |
OLA1 (untagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 2 |
|||
SC323754 | Origene Technologies GmbH | 10 µg | Ask for price |
OLA1 (GFP-tagged) - Human Obg-like ATPase 1 (OLA1), transcript variant 1 |
|||
RG220834 | Origene Technologies GmbH | 10 µg | Ask for price |
OLA1 (GFP-tagged) - Human Obg-like ATPase 1 (OLA1), transcript variant 2 |
|||
RG202094 | Origene Technologies GmbH | 10 µg | Ask for price |
Ola1 (untagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 1, (10ug) |
|||
MC203789 | Origene Technologies GmbH | 10 µg | Ask for price |
Ola1 (GFP-tagged) - Mouse Obg-like ATPase 1 (Ola1) transcript variant 2, (10ug) |
|||
MG218924 | Origene Technologies GmbH | 10 µg | Ask for price |
OLA1 Rabbit pAb |
|||
A11671-100ul | Abclonal | 100 ul | EUR 369.6 |
OLA1 Rabbit pAb |
|||
A11671-200ul | Abclonal | 200 ul | EUR 550.8 |
OLA1 Rabbit pAb |
|||
A11671-20ul | Abclonal | 20 ul | EUR 219.6 |
OLA1 Rabbit pAb |
|||
A11671-50ul | Abclonal | 50 ul | EUR 267.6 |
OLA1 Rabbit pAb |
|||
A4673-100ul | Abclonal | 100 ul | EUR 369.6 |
OLA1 Rabbit pAb |
|||
A4673-200ul | Abclonal | 200 ul | EUR 550.8 |
OLA1 Rabbit pAb |
|||
A4673-20ul | Abclonal | 20 ul | Ask for price |
OLA1 Rabbit pAb |
|||
A4673-50ul | Abclonal | 50 ul | Ask for price |
OLA1 Rabbit pAb |
|||
E2124934 | EnoGene | 100ul | EUR 225 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
OLA1 Rabbit pAb |
|||
E2824934 | EnoGene | 100ul | EUR 225 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Ola1 (Myc-DDK-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 2 |
|||
MR218924 | Origene Technologies GmbH | 10 µg | Ask for price |
Ola1 (Myc-DDK-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 1 |
|||
MR206215 | Origene Technologies GmbH | 10 µg | Ask for price |
OLA1 (Myc-DDK-tagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 2 |
|||
RC202094 | Origene Technologies GmbH | 10 µg | Ask for price |
OLA1 (Myc-DDK-tagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 1 |
|||
RC220834 | Origene Technologies GmbH | 10 µg | Ask for price |
OLA1 Antibody |
|||
47250 | SAB | 100ul | EUR 319 |
OLA1 Antibody |
|||
47250-100ul | SAB | 100ul | EUR 302.4 |
OLA1 Antibody |
|||
E047250 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
OLA1 Antibody |
|||
1-CSB-PA016318GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against OLA1. Recognizes OLA1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
OLA1 Antibody |
|||
1-CSB-PA016318HA01HU | Cusabio |
|
|
Description: A polyclonal antibody against OLA1. Recognizes OLA1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200, IF:1:50-1:200 |
OLA1 Antibody |
|||
E94673 | EnoGene | 100μg | EUR 255 |
Description: Available in various conjugation types. |
OLA1 Antibody |
|||
E305127 | EnoGene | 100ug/200ul | EUR 275 |
Description: Available in various conjugation types. |
OLA1 antibody |
|||
70R-19036 | Fitzgerald | 50 ul | EUR 289 |
Description: Rabbit polyclonal OLA1 antibody |
OLA1 ELISA KIT|Human |
|||
EF010905 | Lifescience Market | 96 Tests | EUR 826.8 |
Olah/ Rat Olah ELISA Kit |
|||
ELI-30503r | Lifescience Market | 96 Tests | EUR 1063.2 |
OLAb/ Rat OLAb ELISA Kit |
|||
ELA-E0617r | Lifescience Market | 96 Tests | EUR 1063.2 |
OLA1 protein (His tag) |
|||
80R-2403 | Fitzgerald | 100 ug | EUR 444 |
Description: Purified recombinant Human OLA1 protein (His tag) |
Lenti ORF clone of Ola1 (mGFP-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 2 |
|||
MR218924L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Ola1 (mGFP-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 1 |
|||
MR206215L4 | Origene Technologies GmbH | 10 µg | Ask for price |
OLA1 (N-term) Rabbit pAb |
|||
E2613169 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
Ola1 ORF Vector (Rat) (pORF) |
|||
ORF071706 | ABM | 1.0 ug DNA | EUR 607.2 |
Lenti ORF clone of Ola1 (Myc-DDK-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 2 |
|||
MR218924L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Ola1 (Myc-DDK-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 1 |
|||
MR206215L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti-ORF clone of OLA1 (mGFP-tagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 2 |
|||
RC202094L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Rat OLA1 shRNA Plasmid |
|||
20-abx988809 | Abbexa |
|
|
Lenti ORF particles, Ola1 (GFP-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 2, 200ul, >10^7 TU/mL |
|||
MR218924L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Ola1 (GFP-tagged) - Mouse Obg-like ATPase 1 (Ola1), transcript variant 1, 200ul, >10^7 TU/mL |
|||
MR206215L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti-ORF clone of OLA1 (Myc-DDK-tagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 2 |
|||
RC202094L3 | Origene Technologies GmbH | 10 µg | Ask for price |
OLA1 cloning plasmid |
|||
CSB-CL016318HU1-10ug | Cusabio | 10ug | EUR 279.6 |
Description: A cloning plasmid for the OLA1 gene. |
OLA1 cloning plasmid |
|||
CSB-CL016318HU2-10ug | Cusabio | 10ug | EUR 279.6 |
Description: A cloning plasmid for the OLA1 gene. |
OLA1 ORF Vector (Human) (pORF) |
|||
ORF007364 | ABM | 1.0 ug DNA | EUR 114 |
OLA1 ORF Vector (Human) (pORF) |
|||
ORF007365 | ABM | 1.0 ug DNA | EUR 114 |
Ola1 ORF Vector (Mouse) (pORF) |
|||
ORF051954 | ABM | 1.0 ug DNA | EUR 607.2 |
Ola1 ORF Vector (Mouse) (pORF) |
|||
ORF051955 | ABM | 1.0 ug DNA | EUR 607.2 |
OLA1 3'UTR GFP Stable Cell Line |
|||
TU066236 | ABM | 1.0 ml | EUR 1825.2 |
Ola1 3'UTR GFP Stable Cell Line |
|||
TU164539 | ABM | 1.0 ml | Ask for price |
Ola1 3'UTR GFP Stable Cell Line |
|||
TU264390 | ABM | 1.0 ml | Ask for price |
Lenti ORF particles, OLA1 (mGFP-tagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 2, 200ul, >10^7 TU/mL |
|||
RC202094L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, OLA1 (Myc-DDK tagged) - Human Obg-like ATPase 1 (OLA1), transcript variant 1, 200ul, >10^7 TU/mL |
|||
RC220834L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, OLA1 (mGFP-tagged) - Human Obg-like ATPase 1 (OLA1), transcript variant 1, 200ul, >10^7 TU/mL |
|||
RC220834L2V | Origene Technologies GmbH | 200 µl | Ask for price |
Preconditioning Impression of Extreme-Depth Interval Teaching (HIIT) and Berberine Supplementation on the Gene Expression of Angiogenesis Regulators and Caspase-Three Protein inside the Rats with Myocardial Ischemia-Reperfusion (IR) Hurt
Objective: It has been confirmed that angiogenesis is a captivating remedy for victims with ischemic coronary coronary heart sickness. We received all the way down to study the have an effect on of high-intensity interval teaching (HIIT) and berberine supplementation on the gene expression of angiogenesis-related parts and caspase-Three protein in rats affected by myocardial ischemic-reperfusion hurt.
Methods: Fifty rats have been divided into the subsequent groups: (1) expert, (2) berberine supplemented, (3) blended, and (4) IR. Each cohort underwent 5 durations of HIIT per week for a interval of Eight weeks adopted by induction of ischemia. Seven days after completion of reperfusion, modifications inside the gene expression of angiogenesis-related parts and caspase-Three protein have been evaluated inside the coronary coronary heart tissue.
Outcomes: We seen a significant distinction between Four groups inside the transcript ranges of vascular endothelial cell growth concern (VEGF), fibroblast growth factor-2 (FGF2), and thrombospondin-1(TSP-1) (p ≤ 0.05). However, the excellence in endostatin (ENDO) ranges was not important among the many many groups no matter a discernible low cost (p ≥ 0.05). Moreover, caspase-Three protein and infarct dimension have been significantly lowered inside the intervention groups (p ≤ 0.05), and cardiac carry out elevated in response to these interventions.
Conclusion: The therapies exert their influence, probably, by reducing caspase-Three protein and rising the expression of angiogenesis-promoting parts, concomitant with a reduction in inhibitors of the strategy.
Explicit miRNA and Gene Deregulation Characterize the Elevated Angiogenic Remodeling of Thoracic Aneurysmatic Aortopathy in Marfan Syndrome
Marfan syndrome (MFS) is a connective tissue sickness introduced on by mutations inside the FBN1 gene, leading to alterations inside the extracellular matrix microfibril assembly and the early formation of thoracic aorta aneurysms (TAAs). Non-genetic TAAs share many clinico-pathological parts with MFS and deregulation of some microRNAs (miRNAs) has been demonstrated to be involved inside the growth of TAA. On this analysis, 40 victims current course of elective ascending aorta surgical process have been enrolled to match TAA histomorphological choices, miRNA profile and related purpose genes with the intention to find specific alterations that can make clear the earlier and further excessive scientific outcomes in MFS victims.
Histomorphological, ultrastructural and in vitro analysis have been carried out with the intention to guage aortic wall choices of MFS and non-MFS TAA. MFS displayed higher glycosaminoglycan accumulation and loss/fragmentation of elastic fibers compared with non-MFS TAA. Immunohistochemistry revealed elevated CD133+ angiogenic remodeling, higher MMP-2 expression, irritation and {{smooth}} muscle cell (SMC) turnover in MFS TAA.
Cultured SMCs from MFS confirmed elevated turnover and α-smooth muscle actin expression in distinction with non-MFS TAA. Moreover, twenty-five miRNAs, along with miR-26a, miR-29, miR-143 and miR-145, have been found to be downregulated and solely miR-632 was upregulated in MFS TAA in vivo.
Bioinformatics analysis revealed that some deregulated miRNAs in MFS TAA are implicated in cell proliferation, extracellular matrix development/carry out and TGFβ signaling. Lastly, gene analysis confirmed 28 upregulated and seven downregulated genes in MFS TAA, a couple of of them belonging to the CDH1/APC and CCNA2/TP53 signaling pathways. Explicit miRNA and gene deregulation characterised the aortopathy of MFS and this was associated to elevated angiogenic remodeling, probably favoring the early and further excessive scientific outcomes, compared with non-MFS TAA.
Our findings current new insights regarding the pathogenetic mechanisms of MFS TAA; further investigation is required to substantiate if these newly acknowledged specific deregulated miRNAs may symbolize potential therapeutic targets to counteract the speedy growth of MFS aortopathy.
Glycitin |
|||
T2820-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Glycitin |
Glycitin |
|||
T2820-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Glycitin |
Glycitin |
|||
T2820-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Glycitin |
Glycitin |
|||
T2820-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Glycitin |
Glycitin |
|||
TB0005 | ChemNorm | 25mg | EUR 223.2 |
Glycitin, >99% |
|||
BC036-005 | GenDepot | 5mg | EUR 230.4 |
Glycitin, >99% |
|||
BC036-010 | GenDepot | 10mg | EUR 295.2 |
Glycitin, >99% |
|||
BC036-025 | GenDepot | 25mg | EUR 360 |
Glycitin 6''-O-Malonate |
|||
G635425 | Toronto Research Chemicals | 100mg | EUR 21000 |
Description: 137705-39-6 |
Glycitein |
|||
540183 | MedKoo Biosciences | 10.0mg | EUR 190 |
Glycitein, >99% |
|||
BC035-005 | GenDepot | 5mg | EUR 278.4 |
Glycitein, >99% |
|||
BC035-010 | GenDepot | 10mg | EUR 375.6 |
Glycitein, >99% |
|||
BC035-025 | GenDepot | 25mg | EUR 489.6 |
Glycitein |
|||
HY-N0016 | MedChemExpress | 10mg | EUR 357.6 |
Glycitein |
|||
GL7698-10 | Glentham Life Sciences | 10 | EUR 152.2 |
Glycitein |
|||
GL7698-25 | Glentham Life Sciences | 25 | EUR 248.6 |
Glycitein |
|||
G635400 | Toronto Research Chemicals | 10mg | EUR 58 |
Description: 40957-83-3 |
Glycitein |
|||
N1785-20 | ApexBio | 20 mg | EUR 160 |
Description: Flavonoid isoflavone |
Glycitein |
|||
T6S0325-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Glycitein |
Glycitein |
|||
T6S0325-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Glycitein |
Glycitein |
|||
T6S0325-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Glycitein |
Glycitein |
|||
T6S0325-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Glycitein |
Glycitein |
|||
T6S0325-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Glycitein |
Glycitein |
|||
TB0372-0020 | ChemNorm | 20mg | EUR 248.4 |
Glycitein-7-O-methyl Ether |
|||
G214700 | Toronto Research Chemicals | 1g | EUR 1200 |
Description: 75199-40-5 |
6''-O-xylosyl-glycitin |
|||
TBW00285 | ChemNorm | 5mg | EUR 1040.4 |
6''-O-xylosyl-glycitin |
|||
TN3194-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: 6''-O-xylosyl-glycitin |
6''-O-xylosyl-glycitin |
|||
TN3194-1g | TargetMol Chemicals | 1g | Ask for price |
Description: 6''-O-xylosyl-glycitin |
6''-O-xylosyl-glycitin |
|||
TN3194-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: 6''-O-xylosyl-glycitin |
6''-O-xylosyl-glycitin |
|||
TN3194-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: 6''-O-xylosyl-glycitin |
6''-O-xylosyl-glycitin |
|||
TN3194-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: 6''-O-xylosyl-glycitin |
Human Glycine(Glycine)ELISA Kit |
|||
YLA3881HU-48T | Shanghai YL Biotech | 48T | Ask for price |
Human Glycine(Glycine)ELISA Kit |
|||
YLA3881HU-96T | Shanghai YL Biotech | 96T | Ask for price |
Glycine |
|||
abx082341-500g | Abbexa | 500 g | EUR 243.6 |
Glycine |
|||
abx082391-500g | Abbexa | 500 g | EUR 226.8 |
Glycine |
|||
20-abx082501 | Abbexa |
|
|
Glycine |
|||
09591-55 | NACALAI TESQUE | 500G | EUR 45.5 |
Glycine |
|||
17109-22 | NACALAI TESQUE | 25G | EUR 8.75 |
Glycine |
|||
17109-35 | NACALAI TESQUE | 500G | EUR 17.43 |
Glycine |
|||
17109-64 | NACALAI TESQUE | 10KG | EUR 127.4 |
Glycine |
|||
17128-14 | NACALAI TESQUE | 100G | EUR 19.6 |
Glycine |
|||
17141-24 | NACALAI TESQUE | 100G | EUR 14 |
Glycine |
|||
17141-95 | NACALAI TESQUE | 500G | EUR 30.8 |
Glycine |
|||
18-107 | Genesee Scientific | 250g/Unit | EUR 32.97 |
Description: Molecular/Proteomic Grade |
Glycine |
|||
18-108 | Genesee Scientific | 500g/Unit | EUR 59.88 |
Description: Molecular/Proteomic Grade |
Glycine |
|||
18-109 | Genesee Scientific | 1000g/Unit | EUR 103.17 |
Description: Molecular/Proteomic Grade |
Glycine |
|||
40700044-1 | Glycomatrix | 500 g | EUR 37.33 |
Glycine |
|||
40700044-2 | Glycomatrix | 1 kg | EUR 60.54 |
Glycine |
|||
40700044-3 | Glycomatrix | 2 kg | EUR 102.65 |
Glycine |
|||
40700044-4 | Glycomatrix | 5 kg | EUR 224.21 |
Glycine |
|||
20-abx184699 | Abbexa |
|
|
Glycine |
|||
A2715-1KG | Biomatik Corporation | 1KG | EUR 46.2 |
Description: Biotechnology |
Glycine |
|||
A2715-500G | Biomatik Corporation | 500G | EUR 26.4 |
Description: Biotechnology |
Glycine |
|||
A2715-5KG | Biomatik Corporation | 5KG | EUR 193.6 |
Description: Biotechnology |
Glycine |
|||
HY-Y0966 | MedChemExpress | 1g | EUR 142.8 |
Glycine |
|||
GM2385-1 | Glentham Life Sciences | 1 | EUR 33.9 |
Glycine |
|||
GM2385-100 | Glentham Life Sciences | 100 | EUR 10.3 |
Glycine |
|||
GM2385-100G | Glentham Life Sciences | 100 g | EUR 44.4 |
Glycine |
|||
GM2385-1KG | Glentham Life Sciences | 1 kg | EUR 60 |
Glycine |
|||
GM2385-250 | Glentham Life Sciences | 250 | EUR 12.3 |
Glycine |
|||
GM2385-250G | Glentham Life Sciences | 250 g | EUR 46.8 |
Glycine |
|||
GM2385-5 | Glentham Life Sciences | 5 | EUR 119.1 |
Glycine |
|||
GM2385-500 | Glentham Life Sciences | 500 | EUR 19.4 |
Glycine |
|||
GM2385-500G | Glentham Life Sciences | 500 g | EUR 51.6 |
Glycine |
|||
GM2385-5KG | Glentham Life Sciences | 5 kg | EUR 112.8 |
Glycine |
|||
G03560 | Pfaltz & Bauer | 100G | EUR 102.1 |
Glycine, 99% |
|||
G0610-100 | GenDepot | 1Kg | EUR 160.8 |
Glycine, 99% |
|||
G0610-500 | GenDepot | 5kg | EUR 361.2 |
Glycine |
|||
G615990 | Toronto Research Chemicals | 10g | EUR 64 |
Description: 56-40-6 |
Glycine |
|||
GB0235 | Bio Basic | 500g | EUR 82.97 |
Glycine |
|||
PCT0310-500G | EWC Diagnostics | 1 unit | EUR 14.98 |
Description: Glycine |
Glycine |
|||
PCT0310-5KG | EWC Diagnostics | 1 unit | EUR 123.27 |
Description: Glycine |
Glycine |
|||
MB013-100G | EWC Diagnostics | 1 unit | EUR 6.93 |
Description: Glycine |
Glycine |
|||
MB013-1KG | EWC Diagnostics | 1 unit | EUR 25.21 |
Description: Glycine |
Glycine |
|||
MB013-500G | EWC Diagnostics | 1 unit | EUR 14.06 |
Description: Glycine |
Glycine |
|||
MB013-5KG | EWC Diagnostics | 1 unit | EUR 81.98 |
Description: Glycine |
glycine |
|||
T2O2728-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: glycine |
glycine |
|||
T2O2728-1g | TargetMol Chemicals | 1g | Ask for price |
Description: glycine |
glycine |
|||
T2O2728-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: glycine |
glycine |
|||
T2O2728-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: glycine |
glycine |
|||
T2O2728-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: glycine |
Glycine |
|||
abx082341-100l | Abbexa | 100 µl | EUR 150 |
Glycine |
|||
abx082341-1ml | Abbexa | 1 ml | Ask for price |
Glycine |
|||
abx082341-200l | Abbexa | 200 µl | Ask for price |
Glycine |
|||
abx082391-100l | Abbexa | 100 µl | EUR 137.5 |
Glycine |
|||
abx082391-1ml | Abbexa | 1 ml | Ask for price |
Glycine |
|||
abx082391-200l | Abbexa | 200 µl | Ask for price |
Glycine |
|||
abx082501-100l | Abbexa | 100 µl | EUR 137.5 |
Glycine |
|||
abx082501-1ml | Abbexa | 1 ml | Ask for price |
Glycine |
|||
abx082501-200l | Abbexa | 200 µl | EUR 187.5 |
(S)-Glycidol |
|||
20-abx181471 | Abbexa |
|
|
Glycine (BSA) |
|||
20-abx165740 | Abbexa |
|
|
Glycine (OVA) |
|||
20-abx165741 | Abbexa |
|
|
Glycine [BSA] |
|||
DAG3313 | Creative Diagnostics | 250ug | EUR 858 |
GLYCINE 2.5KG |
|||
IB70194 | IBI Scientific | - | EUR 118.24 |
GLYCINE 5KG |
|||
IB70195 | IBI Scientific | - | EUR 219.46 |
Glycidol 95% |
|||
G03450 | Pfaltz & Bauer | 25ML | EUR 196.03 |
(S)-(-)-Glycidol |
|||
G615690 | Toronto Research Chemicals | 1g | EUR 58 |
(R)-(+)-Glycidol |
|||
G615695 | Toronto Research Chemicals | 10g | EUR 158 |
Description: 57044-25-4 |
Glycidol |
|||
G615700 | Toronto Research Chemicals | 1g | EUR 80 |
Description: 556-52-5 |
Glycidol (~90%) |
|||
G615703 | Toronto Research Chemicals | 10g | EUR 98 |
Description: 556-52-5 |
Glycine, 1kg |
|||
PR0608-1kg | Vivantis | each | Ask for price |
Glycinol |
|||
TN6568-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Glycinol |
Glycinol |
|||
TN6568-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Glycinol |
Glycinol |
|||
TN6568-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Glycinol |
Glycinol |
|||
TN6568-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Glycinol |
Glycinol |
|||
TN6568-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Glycinol |
Glycine (BSA) |
|||
abx165740-100g | Abbexa | 100 µg | EUR 1912.5 |
Glycine (BSA) |
|||
abx165740-10g | Abbexa | 10 µg | EUR 500 |
Glycine (BSA) |
|||
abx165740-50g | Abbexa | 50 µg | EUR 600 |
Glycine (OVA) |
|||
abx165741-100g | Abbexa | 100 µg | EUR 1962.5 |
Glycine (OVA) |
|||
abx165741-10g | Abbexa | 10 µg | EUR 512.5 |
Glycine (OVA) |
|||
abx165741-50g | Abbexa | 50 µg | EUR 612.5 |
IOX2(Glycine) |
|||
A4189-10 | ApexBio | 10 mg | EUR 72 |
Description: HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor |
IOX2(Glycine) |
|||
A4189-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 68 |
Description: HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor |
IOX2(Glycine) |
|||
A4189-50 | ApexBio | 50 mg | EUR 280 |
Description: HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor |
IOX2(Glycine) |
|||
A4189-S | ApexBio | Evaluation Sample | EUR 22 |
Description: HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor |
Glycine-d2 |
|||
G615991 | Toronto Research Chemicals | 1g | EUR 150 |
Description: 4896-75-7 |
Glycine-d5 |
|||
G615992 | Toronto Research Chemicals | 100mg | EUR 532 |
Description: 4896-77-9 |
Glycine-1-13C-15N |
|||
G615999 | Toronto Research Chemicals | 500mg | EUR 1200 |
Description: 112898-03-0 |
Glycine-N,N,O-d3 |
|||
G616006 | Toronto Research Chemicals | 10mg | EUR 64 |
Description: 4896-76-8 |
Glycidol - 1ML |
|||
S-2087 | Scientific Laboratory Supplies | 1ML | EUR 178.2 |
Glycine (Gly) CLIA Kit |
|||
20-abx490614 | Abbexa |
|
|
Glycine-HCI, 1X |
|||
18-159 | Genesee Scientific | 500ml/Unit | EUR 60.27 |
Description: pH 3.0 |
10X TRIS GLYCINE |
|||
IB01160 | IBI Scientific | SDS BUFFER 1L | EUR 60.92 |
Description: (REF) |
Glycidol-d5 |
|||
G615702 | Toronto Research Chemicals | 100mg | EUR 133 |
Description: 1246819-20-4 |
Glycine-15N |
|||
G615989 | Toronto Research Chemicals | 50mg | EUR 111 |
Glycine-13C |
|||
G615994 | Toronto Research Chemicals | 10mg | EUR 287 |
Description: 20220-62-6 |
Glycine-15N,d2 |
|||
G615996 | Toronto Research Chemicals | 100mg | EUR 224 |
250G Glycine - 250G |
|||
NAT1046 | Scientific Laboratory Supplies | 250G | EUR 59.4 |
Glycine, Hi-AR™/ACS |
|||
GRM199-100G | EWC Diagnostics | 1 unit | EUR 6.93 |
Description: Glycine, Hi-AR™/ACS |
Glycine, Hi-AR™/ACS |
|||
GRM199-250G | EWC Diagnostics | 1 unit | EUR 10.08 |
Description: Glycine, Hi-AR™/ACS |
Glycine, Hi-AR™/ACS |
|||
GRM199-500G | EWC Diagnostics | 1 unit | EUR 12.79 |
Description: Glycine, Hi-AR™/ACS |
Glycine, Hi-AR™/ACS |
|||
GRM199-5KG | EWC Diagnostics | 1 unit | EUR 156.9 |
Description: Glycine, Hi-AR™/ACS |
Glycine (Gly) ELISA Kit |
|||
20-abx258882 | Abbexa |
|
|
Glycine (Gly) ELISA Kit |
|||
EKU10876-48T | Biomatik Corporation | 48T | EUR 690.97 |
Glycine (Gly) ELISA Kit |
|||
EKU10876-5x96T | Biomatik Corporation | 5x96T | EUR 4688.73 |
Glycine (Gly) ELISA Kit |
|||
EKU10876-96T | Biomatik Corporation | 96T | EUR 987.1 |
Glycine (Gly) ELISA Kit |
|||
EKN51987-48T | Biomatik Corporation | 48T | EUR 429.73 |
Glycine (Gly) ELISA Kit |
|||
EKN51987-5x96T | Biomatik Corporation | 5x96T | EUR 2916.03 |
Glycine (Gly) ELISA Kit |
|||
EKN51987-96T | Biomatik Corporation | 96T | EUR 613.9 |
Gly(Glycine) ELISA Kit |
|||
ELK8276-48T | ELK Biotech | 48T | Ask for price |
Description: This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Gly protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Gly. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Gly in the samples is then determined by comparing the OD of the samples to the standard curve. |
Gly(Glycine) ELISA Kit |
|||
ELK8276-96T | ELK Biotech | 96T | Ask for price |
Description: This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Gly protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Gly. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Gly in the samples is then determined by comparing the OD of the samples to the standard curve. |
Glycine (Gly) ELISA Kit |
|||
abx258882-1mg | Abbexa | 1 mg | EUR 6700 |
Glycine (Gly) ELISA Kit |
|||
abx258882-20g | Abbexa | 20 µg | EUR 3537.5 |
Glycine (Gly) ELISA Kit |
|||
abx258882-5g | Abbexa | 5 µg | EUR 743.75 |
Glycidamide |
|||
540182 | MedKoo Biosciences | 100.0mg | EUR 450 |
Glycine Buffer 5X, pH 3.0 |
|||
22050015-1 | Glycomatrix | 100 mL | EUR 31.43 |
Glycine Buffer 5X, pH 3.0 |
|||
22050015-2 | Glycomatrix | 500 mL | EUR 85.98 |
Glycine Buffer 1M, pH 9.0 |
|||
40121188-2 | Glycomatrix | 500 mL | EUR 46.67 |